loader image
Sunday, February 23, 2025
60.7 F
McAllen
We Welcome your Press Release
- Advertisement -

Holistic Approach to Women’s Health and Pregnancy to be Discussed in Valley

Translate to Spanish or other 102 languages!

Mega Doctor News

- Advertisement -

Nurse Midwives, Nurse Practitioner to speak during free “Dessert with the Nurse” event Wednesday
at Valley Baptist in Harlingen

HARLINGEN – Two nurse midwives and a nurse practitioner will speak and answer questions on “Motherhood and Beyond:  Pregnancy, Delivery and Take Caring of the Whole You: A Holistic Approach”, during a free “Dessert with the Nurse” event this Wednesday, August 12 at 6:30 p.m. at Valley Baptist Medical Center, 2101 Pease Street in Harlingen (on the first floor of the hospital, in the Woodward Conference Center).

The speakers will include Nivia Fisch, FACNM, a Fellow in the American College of Nurse-Midwives; Susan Boone, MSN, CHM, RN, Certified Nurse Midwife; and Belinda Ramirez, MSN, WHNP-BC, Women’s Health Nurse Practitioner.

- Advertisement -

The event is free and open to the community and will include a complimentary heart-healthy dessert.  For more information and to RSVP, please call 1-888-902-5433.

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

UPDATE: Measles Outbreak

Mega Doctor News Mega Doctor News  As of February 18, 2025, the Texas...

DHR Health Celebrates 100th Ion Robotic-Assisted Bronchoscopy

DHR Health, a leader in healthcare serving the Rio Grande Valley, announced today that Dr. Federico Vallejo, pulmonologist, has successfully performed his 100th Ion robotic-assisted bronchoscopy.

DHR Health: Pioneering Alzheimer’s Treatment Breakthrough South of San Antonio

DHR Health, a leader in healthcare innovation, proudly announced today its groundbreaking achievement as the first hospital south of San Antonio to successfully administer Leqembi, an FDA-approved medication for the early treatment of Alzheimer’s disease. This milestone demonstrates their expertise and is a significant advancement in healthcare for the Rio Grande Valley.

FDA Approves First CRISPR Gene Therapy to Treat Sickle Cell Disease

Today, the U.S. Food and Drug Administration approved two milestone treatments, Casgevy and Lyfgenia, representing the first cell-based gene therapies for the treatment of sickle cell disease (SCD) in patients 12 years and older.
- Advertisement -
×